Enveric Biosciences, Inc. (ENVB) vs KALA BIO, Inc. (KALA)
A side-by-side comparison of Enveric Biosciences, Inc. and KALA BIO, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENVB
Enveric Biosciences, Inc.
$1.45HealthcareDelayed quote: Oct 6, 2026, 11:56 AM EDT
KALA
KALA BIO, Inc.
$0.37HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — ENVB vs KALA
growth of $100 · dividends reinvested · last 9yENVB -100.0% (-78.8%/yr)KALA -100.0% (-64.5%/yr)KALA compounded faster over this window
Log scale — wide-divergence pair
ENVB KALA
ENVB vs KALA: by the numbers
- •KALA is the larger company ($7M vs $6M market cap).
Metrics side by side
Valuation
| Metric | ENVB | KALA |
|---|---|---|
| P/B ratio | 0.80 | 0.79 |
Profitability
| Metric | ENVB | KALA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -108.00% | -111.46% |
| ROIC | -107.99% | -232.05% |
Growth (annualized)
| Metric | ENVB | KALA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -85.73% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.